EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The potential of exosomes as a new therapeutic strategy for glioblastoma

Leonor Cunha Silva, Francisco Branco, Joana Cunha, Carla Vitorino, Célia Gomes, Mylène A Carrascal, Amílcar Falcão, Bruno Miguel Neves, Maria Teresa Cruz

European Journal of Pharmaceutics and Biopharmaceutics · 2024

DOI: 10.1016/j.ejpb.2024.114460 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2024. Verfasst von Leonor Cunha Silva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, FFUC, University of Coimbra, Coimbra 3000-548, Portugal. Hauptthemen laut MEDLINE: Exosomes, Glioblastoma, Brain Neoplasms, Drug Delivery Systems. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Programa Operacional Temático Factores de Competitividade, Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) stands for the most common and aggressive type of brain tumour in adults. It is highly invasive, which explains its short rate of survival. Little is known about its risk factors, and current therapy is still ineffective. Hence, efforts are underway to develop novel and effective treatment approaches against this type of cancer. Exosomes are being explored as a promising strategy for conveying and delivering therapeutic cargo to GBM cells. They can fuse with the GBM cell membrane and, consequently, serve as delivery systems in this context. Due to their nanoscale size, exosomes can cross the blood-brain barrier (BBB), which constitutes a significant hurdle to most chemotherapeutic drugs used against GBM. They can subsequently inhibit oncogenes, activate tumour suppressor genes, induce immune responses, and control cell growth. However, despite representing a promising tool for the treatment of GBM, further research and clinical studies regarding exosome biology, engineering, and clinical applications still need to be completed. Here, we sought to review the application of exosomes in the treatment of GBM through an in-depth analysis of the scientific and clinical studies on the entire process, from the isolation and purification of exosomes to their design and transformation into anti-oncogenic drug delivery systems. Surface modification of exosomes to enhance BBB penetration and GBM-cell targeting is also a topic of discussion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesGlioblastomaBrain NeoplasmsDrug Delivery SystemsBlood-Brain BarrierAntineoplastic AgentsHumansAnimals

Stichwörter der Autor:innen

BiomimeticCancer treatmentDelivery systemExosomesGene therapyGlioblastomaSurface modification

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Faculty of Pharmacy, FFUC, University of Coimbra, Coimbra 3000-548, Portugal.
  • Faculty of Pharmacy, FFUC, University of Coimbra, Coimbra 3000-548, Portugal; Coimbra Chemistry Centre, Institute of Molecular Sciences - IMS, Department of Chemistry, University of Coimbra, Coimbra 3004 535, Portugal.
  • Coimbra Institute for Clinical and Biomedical Research, iCBR, Faculty of Medicine, University of Coimbra, Coimbra 3000-548, Portugal; Center for Innovation in Biomedicine and Biotechnology, CIBB, University of Coimbra,…
  • Tecnimede Group, Sintra 2710-089, Portugal; Center for Neuroscience and Cell Biology, CNC, University of Coimbra, Coimbra 3004-504, Portugal.
  • Faculty of Pharmacy, FFUC, University of Coimbra, Coimbra 3000-548, Portugal; Coimbra Institute for Biomedical Imaging and Translational Research, CIBIT, University of Coimbra, Coimbra 3000-548, Portugal.
  • Department of Medical Sciences and Institute of Biomedicine, iBiMED, University of Aveiro, Aveiro 3810-193, Portugal.

Förderung

  • Programa Operacional Temático Factores de Competitividade
  • Fundação para a Ciência e a Tecnologia

Zitieren

APA

Cunha Silva, L., Branco, F., Cunha, J., Vitorino, C., Gomes, C., Carrascal, M. A., Falcão, A., Miguel Neves, B., & Teresa Cruz, M. (2024). The potential of exosomes as a new therapeutic strategy for glioblastoma. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2024.114460

Vancouver

Cunha Silva L, Branco F, Cunha J, Vitorino C, Gomes C, Carrascal MA, et al. The potential of exosomes as a new therapeutic strategy for glioblastoma. European Journal of Pharmaceutics and Biopharmaceutics. 2024. doi:10.1016/j.ejpb.2024.114460

BibTeX
@article{CunhaSilva2024,
  author = {Cunha Silva, Leonor and Branco, Francisco and Cunha, Joana and Vitorino, Carla and Gomes, Célia and Carrascal, Mylène A and Falcão, Amílcar and Miguel Neves, Bruno and Teresa Cruz, Maria},
  title = {The potential of exosomes as a new therapeutic strategy for glioblastoma},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2024},
  doi = {10.1016/j.ejpb.2024.114460}
}
Kostenlos starten →